Xin Zhao1, Laura M Palma Medina1, Tim Stobernack1, Corinna Glasner1, Anne de Jong2, Putri Utari3, Rita Setroikromo3, Wim J Quax3, Andreas Otto4, Dörte Becher4, Girbe Buist1, Jan Maarten van Dijl1. 1. University of Groningen , University Medical Center Groningen, Department of Medical Microbiology , Hanzeplein 1 , P.O. Box 30001, 9700 RB Groningen , The Netherlands. 2. University of Groningen , Groningen Biomolecular Sciences and Biotechnology Institute, Department of Molecular Genetics , 9747 AG Groningen , The Netherlands. 3. University of Groningen , Groningen Research Institute of Pharmacy, Department of Chemical and Pharmaceutical Biology , A. Deusinglaan 1 , 9713 AV Groningen , The Netherlands. 4. Institut für Mikrobiologie , University of Greifswald , Felix-Hausdorff-Str. 8 , 17475 Greifswald , Germany.
Abstract
Staphylococcus aureus with spa-type t437 has been identified as a predominant community-associated methicillin-resistant S. aureus clone from Asia, which is also encountered in Europe. Molecular typing has previously shown that t437 isolates are highly similar regardless of geographical regions or host environments. The present study was aimed at assessing to what extent this high similarity is actually reflected in the production of secreted virulence factors. We therefore profiled the extracellular proteome, representing the main reservoir of virulence factors, of 20 representative clinical isolates by mass spectrometry. The results show that these isolates can be divided into three groups and nine subgroups based on exoproteome abundance signatures. This implies that S. aureus t437 isolates show substantial exoproteome heterogeneity. Nonetheless, 30 highly conserved extracellular proteins, of which about 50% have a predicted role in pathogenesis, were dominantly identified. To approximate the virulence of the 20 investigated isolates, we employed infection models based on Galleria mellonella and HeLa cells. The results show that the grouping of clinical isolates based on their exoproteome profile can be related to virulence. We consider this outcome important as our approach provides a tool to pinpoint differences in virulence among seemingly highly similar clinical isolates of S. aureus.
Staphylococcus aureus with spa-type t437 has been identified as a predominant community-associated methicillin-resistant S. aureus clone from Asia, which is also encountered in Europe. Molecular typing has previously shown that t437 isolates are highly similar regardless of geographical regions or host environments. The present study was aimed at assessing to what extent this high similarity is actually reflected in the production of secreted virulence factors. We therefore profiled the extracellular proteome, representing the main reservoir of virulence factors, of 20 representative clinical isolates by mass spectrometry. The results show that these isolates can be divided into three groups and nine subgroups based on exoproteome abundance signatures. This implies that S. aureus t437 isolates show substantial exoproteome heterogeneity. Nonetheless, 30 highly conserved extracellular proteins, of which about 50% have a predicted role in pathogenesis, were dominantly identified. To approximate the virulence of the 20 investigated isolates, we employed infection models based on Galleria mellonella and HeLa cells. The results show that the grouping of clinical isolates based on their exoproteome profile can be related to virulence. We consider this outcome important as our approach provides a tool to pinpoint differences in virulence among seemingly highly similar clinical isolates of S. aureus.
Entities:
Keywords:
-type; HeLa cells; ST59; exoproteome; t437; virulence
The Gram-positive bacterium Staphylococcus aureus is a causative agent of different
nosocomial and community-acquired
diseases that may range from mild superficial skin infections to serious
invasive disease.[1] In recent years, S. aureus infections have become increasingly difficult
to treat due to the acquisition of high-level antibiotic resistance,
as underpinned by methicillin-resistant S. aureus (MRSA) lineages that are also resistant to other classes of antibiotics.[2]To facilitate local surveillance and to
monitor the global spread
of drug-resistant S. aureus lineages, molecular
approaches such as multilocus sequence typing (MLST) and spa-typing have been developed. These have shown that certain clones
of S. aureus are frequently prevalent in particular
regions of the world. For example, the clone with sequence type (ST)
59, which is linked with the spa-type t437, is one
of the most dominant community-acquired (CA)-MRSA clones in Asia[3] and Western Australia.[4,5] In
the period from 2016 to 2017, S. aureus ST59-MRSA-t437
was reported as the predominant CA-MRSA clone in Chinese children,
which appears to relate to a strong ability to form biofilms.[6] Several studies have shown that the ST59 clone
has also spread to European countries.[7,8] In particular,
by MLST and multiple-locus variable number tandem repeat analysis
(MLVA) of 147 S. aureus isolates with spa-type t437 from 11 different European countries, it was
shown that these isolates represent a genetically tight cluster irrespective
of the country of isolation, the year of isolation or the specific
host situation.[8] It was therefore concluded
that the S. aureus lineage with spa-type t437 has the features
of a potentially high-risk clone.The ability of S. aureus to cause infections
relates to the expression of a wide variety of virulence factors.[9] These proteins play decisive roles in promoting
the colonization of the human host, invasion of cells and tissues,
and evasion of the innate and adaptive immune responses. Interestingly,
only few staphylococcal virulence factors, such as the toxic shock
syndrome toxin or exfoliative toxins, can be directly associated with
particular disease phenotypes.[10−12] Instead, in most infections a
highly potent cocktail of virulence factors is employed by S. aureus to breach the barriers imposed by the skin
and mucosal tissues and to invade the human body.[13,14] Early proteomics studies have shown that the assembly of virulence
factors produced by S. aureus is highly variable
for different clonal lineages.[15] This can
be attributed in particular to the high genomic plasticity of the S. aureus genome, which is shaped by successive events
of horizontal gene transfer as exemplified by the presence of prophages,
staphylococcal pathogenicity islands, and the staphylococcal cassette
chromosome responsible for methicillin resistance. On the other hand,
very little is known about possible variations in the production of
virulence factors by different clinical isolates of one particular
clonal lineage of S. aureus. Yet, insights in
such variations are needed to understand the extent to which they
determine different degrees of staphylococcal virulence and to assess
the health risks imposed by individual clinical isolates.The
extracellular proteome (in short exoproteome) of bacterial
pathogens, like S. aureus, is considered as
the main reservoir of virulence factors.[9,16] In the present
study, we profiled the composition of the exoproteomes of 20 clinical S. aureus isolates with spa-type t437
to assess the extent to which the production of virulence factors
and other secreted proteins may vary among this genetically highly
homogeneous group of S. aureus isolates. As
a first approach to assess the possible implications of the observed
variations, we employed larvae of the greater wax mothGalleria
mellonella, an infection model that was previously shown
to be susceptible to a range of human pathogens.[17] Importantly, upon injection into the larvae, bacteria are
challenged directly by an innate immune system, which is functionally
and structurally equivalent to that of mammals.[18] Subsequently, we applied the humanHeLa cancer cell line
for high-throughput profiling of invasion and cytotoxicity of the
investigated S. aureus t437 isolates in nonprofessional
phagocytic cells. Briefly, the results of our present study show that
the investigated S. aureus t437 clinical isolates
can be divided into three groups and nine subgroups based on their
exoproteome profiles, and that isolates belonging to particular subgroups
show similarities in virulence when confronted with the innate immune
defenses of G. mellonella. In contrast, relatively
smaller variations were observed in the HeLa cell infection model,
which assays the efficiency of nonprofessional phagocyte invasion
and subsequent killing. It thus seems that the observed variations
in the exoproteomes of different S. aureus t437
isolates do not have the same impact in the two infection models which,
most likely, reflects the fact that these models impose different
challenges on infecting bacteria. A comparative analysis of the present
scale, relating staphylococcal exoproteome composition to virulence,
is unprecedented. Importantly, this approach represents an effective
pipeline to define proteomic signatures of S. aureus virulence.
Materials and Methods
Bacterial Isolates
A total of 20 S. aureus
spa-type t437 isolates was used for exoproteome analyses
in the present study (Table ). Ten of these isolates were selected from the MLVA type
(MT) 621 group, which has been shown to represent the most predominant
class of S. aureus t437 isolates; the other
ten isolates belong to different MTs as indicated in Table .
Table 1
Genotypic
and Epidemiological Characteristics
of the 20 S. aureus t437 Study Isolates
isolate
MLVA complex
MLVA type
country of origin
year of isolation
mecA gene
pvl gene
source
Q1–15
621
1870
France
2004
positive
positive
unknown
Q1–24
621
621
Denmark
2010
positive
positive
SSTI
Q1–54
621
1035
Scotland
2012
positive
positive
skin
Q1–57
621
1297
Spain
2011
positive
negative
SSTI
Q1–59
621
2075
Hungary
2008
positive
positive
throat
Q1–71
621
1875
Netherlands
2005
positive
positive
SSTI
Q1–93
621
621
Netherlands
2006
positive
positive
nose
Q2–101
621
2322
Netherlands
2007
positive
positive
nose
Q2–141
621
4183
Norway
2013
positive
positive
nose
Q2–153
621
621
China
2009
negative
negative
unknown
Q2–146
none
3560
China
2008–2009
positive
positive
unknown
Q2–142
621
621
China
2011
positive
positive
unknown
Q2–116
621
1831
Netherlands
2009
negative
positive
skin
Q3–143
621
621
China
2008–2009
positive
positive
unknown
Q3–147
621
621
China
2010
positive
negative
unknown
Q3–66
621
621
Netherlands
2004
positive
positive
nose
Q3–32
621
4125
Scotland
2008
negative
positive
skin
Q3–107
621
621
Netherlands
2007
positive
positive
wound
Q3–104
621
621
Netherlands
2007
positive
positive
nose
Bacterial Cultivation and Collection of Extracellular Proteins
Bacterial cultivation and extracellular protein extraction were
carried out as described previously.[19] Briefly,
all bacterial isolates were grown in triplicate overnight (14–16
h) in 10 mL tryptic soy broth (TSB, OXOID, Basingstoke, UK) under
vigorous shaking (115 rpm) at 37 °C in a water bath. The cultures
were then diluted into 10 mL prewarmed Roswell Park Memorial Institute
1640 (RPMI) medium supplemented with 2 mM glutamine (GE Healthcare/PAA,
Little Chalfont, United Kingdom) to an optical density at 600 nm (OD600) of 0.1 and cultivation was continued under the same conditions.
Exponentially growing cells with an OD600 of ±0.5
were again diluted into 20 mL of fresh prewarmed RPMI 1640 medium
to a final OD600 of 0.1 and their cultivation was continued
until an OD600 of ±1.3 was reached, which corresponds
to the stationary growth phase. Then, growth medium fractions were
collected by centrifugation. Proteins in the growth medium were precipitated
overnight with 10% trichloroacetic acid (TCA, Sigma-Aldrich, St. Louis,
USA) on ice. The precipitated proteins were collected by centrifugation.
Pellets of precipitated proteins were washed once with ice-cold acetone,
dried at room temperature and stored at −20 °C until further
use.
LDS-PAGE and Western Blotting
To inspect extracellular
proteins by lithium dodecyl sulfate (LDS) polyacrylamide gel electrophoresis
(PAGE), TCA-precipitated proteins were resuspended in LDS sample buffer
and separated on NuPAGE gels (Life Technologies, Grand Island, NY.
USA). The separated proteins were visualized by Simply Blue Safe Staining
(Life Technologies). The presence of IsaA was assessed by Western
blotting using Protran nitrocellulose transfer paper (Whatman, Germany)
and immunodetection using the IRDye 800CW-labeled 1D9 monoclonal antibody
that is specific for IsaA.[20] Antibody binding
was detected using an Odyssey Infrared Imaging System (LI-COR Biosciences,
Lincoln, NE. USA).
Protease Activity Profiling
To assess
the activity
of proteases in the growth medium of the investigated S. aureus t437 isolates in the stationary growth phase, we applied His6-tagged derivatives of the S. aureus IsaA and SCIN proteins that were recombinantly produced in Lactococcus lactisNZ9700 as described previously.[21] Specifically, 500 μL aliquots of L. lactis growth medium containing recombinant IsaA
or SCIN were mixed with 500 μL aliquots of spent growth media
(RPMI 1640) of the 20 investigated S. aureus t437 isolates and incubated overnight at 37 °C. Of note, prior
to this incubation, cells of L. lactis and S. aureus had been removed from the respective growth
medium fractions by centrifugation. After the overnight incubation,
proteins in the incubation mixtures were precipitated overnight at
4 °C with 10% TCA, and separated by LDS-PAGE. The presence of
His6-tagged IsaA or SCIN was then assessed by Western blotting
using His6-specific antibodies (Invitrogen, Canada).
Sample Preparation for Mass Spectrometry
Collected
extracellular proteins were processed for Mass Spectrometry (MS) analysis
essentially as described previously.[22] In
brief, the dried protein pellets were resuspended in 50 mM ammonium
bicarbonate buffer (Fluka, Buches, Switzerland) and reduced with 500
mM dithiothreitol (DTT, Duchefa Biochemie, The Netherlands) for 45
min at 60 °C. The samples were then alkylated with 500 mM iodoacetamide
(IAA, Sigma-Aldrich) and incubated for 15 min in the dark at room
temperature. 100 ng of sequencing grade modified trypsin (Promega,
Madison, USA) were added and the mixture was incubated overnight at
37 °C under continuous shaking at 250 rpm to completely digest
the proteins. Subsequently, the samples were acidified with a final
concentration of 0.1% trifluoroacetic acid (TFA, Sigma-Aldrich, St.
Louis, USA) for 45 min at 37 °C to inactivate the trypsin. The
digested peptides were purified with C-18 ZipTips (Millipore, Billerica,
USA). The ZipTips were first wetted with 45 μL 70% acetonitrile
(ACN, Fluka, Buchs, Switzerland) and then equilibrated with 45 μL
3% ACN/0.1% acetic acid. Peptides were bound to the ZipTips by pipetting
10 times up and down. After washing with 45 μL 0.1% MS-acetic
acid, the ZipTips were eluted with 45 μL 60% ACN/0.1% MS-acetic
acid. Lastly, the eluted peptides were dried in a SpeedVac (Eppendorf,
Hamburg, Germany) at room temperature. The dried samples were stored
at 4 °C until further use.
Mass Spectrometry Analyses
Purified peptides were identified
by reversed-phase liquid chromatography coupled to electrospray ionization
mass spectrometry (MS) using an LTQ Orbitrap XL (Thermo Fisher Scientific,
Waltham, MA) as described by Stobernack et al.[22] In brief, Sorcerer-SEQUEST 4 (Sage-N Research, Milpitas,
USA) was applied for database searching, and raw data files were searched
with SEQUEST against a target-decoy database. The nonredundant database
that was used for protein identifications was based on published genome
sequences of the S. aureus isolates with ST2147,
ST59, or ST338 (downloaded from https://www.ncbi.nlm.nih.gov/), which represent the dominant STs of S. aureus t437.[8] This database includes 7187 protein
sequences with connected gene names and Uniprot identifiers. Validation
of MS/MS-based peptide and protein identification was performed with
Scaffold V4.7.5 (Proteome Software, Portland, USA), and peptide identifications
were accepted if they exceeded the specific database search engine
thresholds. SEQUEST identifications required at least deltaCn scores
of greater than 0.1 and XCorr scores of greater than 2.2, 3.3, and
3.75 for doubly, triply and all higher charged peptides, respectively.
Protein identifications were accepted if at least 2 identified peptides
were detected with the above-mentioned filter criteria in 2 out of
3 biological replicates. Protein data was exported from Scaffold and
curated in Microsoft Excel before further analyses (Tables S1 and S2). Since we observed
large differences in the total spectral counts, the normalization
of the data was not performed over all data sets simultaneously, because
this would over-represent the quantities of proteins in samples with
fewer protein identifications. Instead, the data sets for different
isolates were clustered into three groups (Q1–3) based on the
total spectral counts, and each group was mean-normalized as recommended
in the Scaffold software for spectral counting data sets (https://proteomesoftware.zendesk.com/hc/en-us/articles/115002739586-Spectrum-Count-Normalization-in-Scaffold).
Assessment of Virulence with a Galleria mellonella Infection Model
To evaluate the virulence of investigated S. aureus t437 isolates using G. mellonella, larvae of ∼250 mg in the final instar stage were purchased
(Frits Kuiper, Groningen, Netherlands) and stored in the dark at room
temperature. The larvae were used for infection experiments within
7 days of receipt. Until then, they were fed with wood shavings. Prior
to an infection experiment, bacteria were grown overnight in TSB medium
and collected by centrifugation at 2700g for 10 min
at 4 °C. The cell pellets were washed by resuspension in phosphate-buffered
saline (PBS), collected by centrifugation, resuspended in PBS, and
diluted to the desired number of colony-forming units (CFU) per mL
as approximated based on the optical density at OD600 of
the overnight culture. Infections were performed by inoculating the
larvae with 10 μL aliquots of a bacterial suspension in PBS
(2.5 × 106 CFU) into the hemocoel via the last left
proleg using an insulin pen (HumaPen LUXURA HD, Indianapolis, USA).[23] After injection, the larvae were kept in Petri
dishes in the dark at 37 °C, and mortality was monitored after
24 and 48 h post infection. Larvae were considered dead when they
displayed no movement after being touched with a sterile inoculation
loop. The virulence of each investigated S. aureus t437 isolate was tested in triplicate using 15 larvae per experiment
(n = 45), and for each of these three biological
replicates larvae from different batches were used. Data from all
infection experiments were combined to calculate the average mortality.
For control, one group (n = 15) of larvae was injected
with 10 μL of PBS to monitor the impact of physical trauma,
a second group (n = 15) was injected with 2.5 ×
107 CFU of heat-killed bacteria to monitor potentially
lethal effects caused by toxic bacterial components, and a third group
(n = 15) received no injection at all.To verify
possible roles in virulence of the extracellularly identified proteins
IsdA, IsdB and IsaA, specific single mutant strains and the respective
parental strains USA300 LAC (for isaA or isdB mutations)[24] and SH1000
(for the isaA mutation)[25] were used to infect G. mellonella larvae.
In this case, the larvae were inoculated as described above, but with
1 × 106 CFU of bacteria. The larval survival was monitored
from 24 h until 96 h post infection. Each bacterial isolate was used
to inoculate 10 larvae per experiment, and all experiments were performed
in triplicate.
Assessment of Staphylococcal Cytotoxicity
with a HeLa Cell Infection
Model
The human cervical cancerHeLa cell line was cultured
in DMEM-GlutaMAX medium (Gibco, UK) supplemented with 10% fetal calf
serum (Sigma-Aldrich, USA) at 37 °C and 5% CO2. 0.25%
Trypsin-EDTA (Gibco, UK) was used to detach adherent cells for subculturing.
3 × 104 HeLa cells in a total volume of 100 μL
were incubated in 96-well plates for 24 h. Next the HeLa cells were
infected with 1.5 × 106 bacteria in PBS (multiplicity
of infection [MOI] 50:1), which had been obtained from overnight cultures
in TSB medium, washed in PBS and resuspended in PBS. The infectedHeLa cells were then incubated at 37 °C and 5% CO2 for 2 h. After 2 h of infection, the plates were washed 3 times
with PBS to remove unbound bacteria and, subsequently, lysostaphin
(AMBI Products, NY, USA) was added at a final concentration of 20
μg/mL to eliminate the extracellular bacteria. Incubation was
continued for another 2 h, and then 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT; Sigma-Aldrich, NL) was added to a final concentration
of 0.5 mg/mL to evaluate the viability of the infectedHeLa cells.
The plates with added MTT were incubated at 37 °C and 5% CO2 for 3 h. Lastly, the cells were resuspended in 150 μL
of acidic isopropanol, and the absorbance of the suspension was measured
at 570 nm. The cytotoxicity of individual S. aureus isolates was expressed as the absorbance at 570 nm relative to the
control of HeLa cells incubated in the absence of infecting S. aureus cells.
Bioinformatic and Statistical
Analyses
Bioinformatic
tools including TMHMM (version 2.0),[26] SignalP
(version 4.1),[27] LipoP (version 1.0),[28] PsortB (version 3.0.2),[29] ProtCompB (version 9.0),[30] and SecretomeP
(version 2.0)[31] were used for the prediction
of subcellular location of proteins identified by MS analyses. Biological
processes and gene annotations were assigned based on the previously
annotated S. aureus strain NCTC8325, using the
AureoWiki database (http://aureowiki.med.uni-greifswald.de). To visualize protein
functions and the respective protein abundances, Voronoi treemaps
were built using Paver version 2.1 (Decodon GmnH, Greifswald, Germany).[32] To elucidate relationships between samples of
particular groups that had been distinguished based on their exoproteome
profiles, correlation coefficients were calculated and principal component
analyses were performed on the basis of the MS data using R version
3.4.2.[33] Spearman correlation coefficients
were computed with the cor function using a pairwise
comparison (R package: stats). A k-means clustering
analysis was performed by clustering the data with the kmeans function (R package: stats) and the outcomes were visualized with fviz_cluster (R package: factoextra).[34] Significant differences in protein spectral counts between
isolates belonging to one group were assessed by ANOVA tests (aov) and subsequently by the Tukey’s Honest Significant
Difference (TukeyHSD) method (R package: stats). The statistical significance
of differences in the killing of G. mellonella larvae by the S. aureus t437 Q1–3,a–c
subgroups was assessed by Wilcoxon tests and a subsequent Bonferroni
correction to adjust the P-values using the SAS/STAT
software package (version 9.4). The statistical significance of differences
in the killing of HeLa cells by the S. aureus t437 Q1–3 groups was assessed by ANOVA tests, and a TukeyHSD
test was applied for subgroup comparisons using the SAS/STAT software
package.
Biological and Chemical Safety
S. aureus is a biosafety level 2 (BSL-2) microbiological agent and was accordingly
handled following appropriate safety procedures. All experiments involving
live S. aureus bacteria and chemical manipulations
of S. aureus protein extracts were performed
under appropriate containment conditions, and protective gloves were
worn. All chemicals and reagents used in this study were handled according
to the local guidelines for safe usage and protection of the environment.
Data Availability
The mass spectrometry data are deposited
in the ProteomeXchange repository PRIDE (https://www.ebi.ac.uk/pride/). The data set identifier is PXD009082.
Results
Exoproteome
Quantification Distinguishes Three Groups of S. aureus t437 Isolates
To identify possible
variations in the exoproteomes of previously collected S. aureus t437 clinical isolates, we selected 20 different isolates, cultured
them in RPMI medium to the stationary phase, and collected the secreted
proteins from the growth medium fraction by TCA precipitation. Of
note, RPMI medium was used for this study, because previous analyses
had shown that the global gene expression profiles of S. aureus grown in RPMI medium closely resemble those of S. aureus grown in human plasma.[35] As can be expected
when working with clinical S. aureus isolates,
we detected some variations in growth among the investigated S. aureus isolates, but these related mainly to the
lag phase (Figure S1). Further, extracellular
proteins were collected in the stationary phase, because the majority
of virulence factors are secreted during this particular growth phase.[36] Interestingly, the banding patterns of extracellular
proteins and their relative intensities showed clear variations in
Simply Blue-stained LDS-PAGE gels (Figure S2). This was indicative of exoproteome heterogeneity among the 20
investigated isolates, a notion that was subsequently verified by
close inspection of the MS data (Table S2). First, among the total of 303 different identified extracellular
proteins, only 23 were found to be shared by all investigated isolates,
whereas 102 proteins were uniquely identified for one or two isolates.
Second, calculation of total spectral counts revealed substantial
variations in the abundance of extracellular proteins between the
different isolates, ranging from 186 for isolate 15 to 1404 for isolate
31 (Figure ). Since
this wide range precluded a reliable normalization of total spectral
counts, we divided the isolates into three groups (Q1–3) based
on the numbers of total spectral counts measured for their extracellular
proteins (Table S2). Specifically, the
total spectral counts of exoproteins for the Q1 isolates ranged from
186 to 500, for Q2 isolates from 730 to 995, and for Q3 isolates from
1009 to 1404. In accordance with this significant variation, also
the total numbers of identified proteins per group differed substantially,
ranging between 25 proteins for Q1 (isolate 15) and 198 proteins for
Q3 (isolate 31; Figure ). Further, in the Q1 group, 87 distinct exoproteins were identified
for all 7 isolates, while 41.3% of the exoproteins were uniquely identified
for one or two strains. In the Q2 group, 50% of the 220 identified
proteins were uniquely identified for one or two isolates. In the
Q3 group, 36.3% of the 303 identified proteins were unique for all
7 isolates. As an alternative to the initial grouping based on total
spectral counts, we verified the clustering of the investigated isolates
by the total numbers of identified proteins. This yielded a very similar
distribution of the investigated isolates over the Q1–3 groups
(Table S3). However, since the total numbers
of spectral counts present more information concerning extracellular
protein abundance, we decided to use the group classification based
on spectral counts for our further analyses. Together, these findings
imply that essentially three different exoproteome abundance types
can be distinguished among the 20 investigated S. aureus t437 isolates. Importantly, this distinction is independent of the
country of origin, year of isolation, MLVA type and source (Figure , Table ).
Figure 1
Overview of the numbers
of identified extracellular proteins of S. aureus t437 isolates and their predicted subcellular
locations. On the basis of the numbers of total spectral counts measured
for their extracellular proteins, the 20 S. aureus t437 study isolates were assigned to three groups designated Q1–3.
For each identified extracellular protein, the subcellular location
was predicted bioinformatically and the respective numbers of proteins
assigned to each subcellular location are indicated in color code.
The averaged total numbers of spectral counts measured for the extracellular
protein samples from each isolate are presented below the isolate
numbers.
Overview of the numbers
of identified extracellular proteins of S. aureus t437 isolates and their predicted subcellular
locations. On the basis of the numbers of total spectral counts measured
for their extracellular proteins, the 20 S. aureus t437 study isolates were assigned to three groups designated Q1–3.
For each identified extracellular protein, the subcellular location
was predicted bioinformatically and the respective numbers of proteins
assigned to each subcellular location are indicated in color code.
The averaged total numbers of spectral counts measured for the extracellular
protein samples from each isolate are presented below the isolate
numbers.
Exoproteome Heterogeneity
in S. aureus t437 Relates Predominantly to Differential
Abundance of Extracellular
Cytoplasmic Proteins (ECP)
To assess the nature of the identified
proteins, we inspected their predicted subcellular localization with
different bioinformatics tools. This showed that the largest level
of variation was related to the extracellular appearance of typical
cytoplasmic proteins that lack known targeting signals for export
from the cytoplasm (Figure ). The numbers of observed extracellular cytoplasmic proteins
were, over all, lowest for the Q1 isolates and highest for the Q3
isolates, ranging from four to 154 (Figure ). Conversely, differences in the numbers
of predicted extracellular proteins with signal peptides for export
from the cytoplasm were much smaller. Specifically, for the different
isolates, we identified 15–40 typical secretory proteins, 5–12
cell wall-associated proteins, 2–12 lipoproteins, and 1–12
membrane-associated proteins. The observed exoproteome heterogeneity
both in terms of identified proteins and their relative abundance
based on normalized spectral counts, is reflected in the heat maps
for the Q1, Q2, and Q3 groups of isolates presented in Figure A and Table S4. These heat maps show that the greatest heterogeneity is
observed for exoproteins that are present in relatively low abundance.
Intriguingly, typical cytoplasmic proteins appear to be overrepresented
in this heterogeneous group of low abundance proteins (Figure A). In contrast, the majority
of the 30 most abundant extracellular proteins is known to be exported
from the cytoplasm with the aid of signal peptides (Figure A,B). A representative of the
latter class of proteins is the well-characterized immunodominant
staphylococcal antigen A (IsaA),[25,37] which was
used to validate the quantitative proteomics data in a Western blot
with the aid of a previously developed IsaA-specific monoclonal antibody.[38] As shown in Figure C, the relative spectral count measurements
for IsaA and the Western blotting data are fully consistent, providing
conclusive support for the exoproteome heterogeneity as mapped by
mass spectrometry. Together, these observations show that the exoproteome
heterogeneity observed for S. aureus t437 isolates
is largely related to a differential abundance of extracellular cytoplasmic
proteins.
Figure 2
Exoproteome abundance profiles of the investigated S. aureus t437 isolates within the Q1–3 groups. (A) Heat-map showing
the relative amounts of the identified extracellular proteins within
the three Q1–3 isolate groups based on normalized total spectral
counts. Color-coded bars within each heatmap represent identified
proteins and the isolate numbers are indicated on top of each lane.
The black and gray bars flanking each heatmap indicate the relative
abundance of extracellular proteins with a predicted cytoplasmic location
(gray) versus extracellular proteins with a predicted extracytoplasmic
location; each of the respective clusters represents 30 proteins.
(B) The 30 most abundant and conserved identified extracellular proteins
and their respective descriptions. (C) Comparison of the relative
spectral count measurements for IsaA and a Western blot decorated
with the monoclonal antibody 1D9 that is specific for IsaA. (D) Protease
activity in the growth medium of the investigated S. aureus t437 isolates was assessed by assaying the stability of recombinantly
produced His6-tagged IsaA and SCIN proteins added to spent
growth medium samples and subsequent Western blotting with His6-specific antibodies.
Exoproteome abundance profiles of the investigated S. aureus t437 isolates within the Q1–3 groups. (A) Heat-map showing
the relative amounts of the identified extracellular proteins within
the three Q1–3 isolate groups based on normalized total spectral
counts. Color-coded bars within each heatmap represent identified
proteins and the isolate numbers are indicated on top of each lane.
The black and gray bars flanking each heatmap indicate the relative
abundance of extracellular proteins with a predicted cytoplasmic location
(gray) versus extracellular proteins with a predicted extracytoplasmic
location; each of the respective clusters represents 30 proteins.
(B) The 30 most abundant and conserved identified extracellular proteins
and their respective descriptions. (C) Comparison of the relative
spectral count measurements for IsaA and a Western blot decorated
with the monoclonal antibody 1D9 that is specific for IsaA. (D) Protease
activity in the growth medium of the investigated S. aureus t437 isolates was assessed by assaying the stability of recombinantly
produced His6-tagged IsaA and SCIN proteins added to spent
growth medium samples and subsequent Western blotting with His6-specific antibodies.It was previously shown for another Gram-positive bacterium, Bacillus subtilis, that the appearance of extracellular
cytoplasmic proteins can be suppressed by protease activity in the
bacterial growth medium.[39] To investigate
whether proteolytic activity might impact on the extracellular protein
abundance, we assessed the possible degradation of the recombinantly
produced S. aureus proteins IsaA and SCIN in
spent media of the 20 investigated S. aureus t437 isolates. The advantage of using these proteins as markers
for proteolytic activity is that both of them contain a C-terminal
His6 tag that allows their distinction from the respective
native proteins secreted by the investigated S. aureus isolates. Upon overnight incubation in the spent media at 37 °C,
the presence of recombinant IsaA and SCIN was assessed by Western
blotting with His6-specific antibodies. On balance, the
highest levels of IsaA and SCIN degradation were observed upon incubation
in spent media from isolates of the Q3 group (Figure D). This implies that the respective media
contain the highest protease levels, which is consistent with the
finding that the cysteine protease staphopain A was most abundantly
identified in media of Q3 isolates, and that the zinc metalloprotease
aureolysin and the cysteine protease SsaA1 were most abundantly detected
in media of Q2 and Q3 isolates (Table S4). In fact, SsaA1 was not detectable in the media of Q1 isolates.
This implies that the relatively high abundance of extracellular cytoplasmic
proteins in media of the Q3 isolates cannot be correlated to protease
activity as was previously shown for Bacillus.
S. aureus t437 Groups Q1, Q2, and Q3 Include
Subclusters of Isolates with Distinctive Exoproteome Abundance Signatures
To elucidate possible exoproteome relationships among the isolates
of each group, Spearman correlation and k-means clustering
analyses were performed on the basis of protein identifications and
the respective protein abundance. For both types of analyses, the
normalized total spectral counts of proteins that were produced by
all the isolates within each group were used. The Spearman analysis
revealed that isolates within the Q2 group are relatively homogeneous
with respect to their exoprotein abundance signatures as compared
to isolates in the Q1 and Q3 groups (Figure A). In the Q1 group, isolate 15 seems relatively
less related to the other isolates in this group, and in the Q3 group
the same applies for isolate 31. As shown in Figure B, the k-means clustering
analyses provided another angle to elucidate possible exoproteome
relationships between isolates, showing that each group of S. aureus t437 isolates (Q1–3) can be subdivided
into three distinct subgroups (a,b,c). Following this subdivision
based on differences in protein abundance (as assessed by k-means clustering), differences in the number of protein
identifications for each subgroup were determined. The Venn diagrams
in Figure S3 show the numbers of core and
variant extracellular proteins identified for each group. Taken together,
the results from these analyses show that each of the Q1–3
groups, which were initially distinguished based on the total spectral
counts measured for their exoproteins, is composed of isolates with
three different exoproteome abundance signatures.
Figure 3
Clustering of isolates
within each group based on exoproteome abundance
signatures by Spearman correlation and principal component analysis.
(A) Spearman correlation of the normalized total spectral counts of
identified extracellular proteins within the Q1–3 groups. (B) k-means clustering analysis based on the normalized total
spectral counts of the identified extracellular proteins. Two-dimensional k-means plots further divide each Q-group into three subgroups
(a,b,c).
Clustering of isolates
within each group based on exoproteome abundance
signatures by Spearman correlation and principal component analysis.
(A) Spearman correlation of the normalized total spectral counts of
identified extracellular proteins within the Q1–3 groups. (B) k-means clustering analysis based on the normalized total
spectral counts of the identified extracellular proteins. Two-dimensional k-means plots further divide each Q-group into three subgroups
(a,b,c).
The Core and Variant Exoproteomes
of S. aureus t437 Isolates Have Apparently Distinctive
Roles in Pathogenesis
and Cellular Functions
Despite the heterogeneity observed
in the exoproteome profiles of the investigated S. aureus t437 isolates, there are nonetheless 30 highly abundant “core”
proteins consistently detected (≥80%) in the exoproteomes of
all three groups of isolates of which about 50% have a role in virulence
(Figure B). This implies
that their dominant expression is characteristic for the core exoproteome
of isolates from this particular staphylococcal lineage. To further
zoom in on the collective and variant biological functions of the
identified extracellular proteins of the Q1–3 groups, a functional
classification based on the annotation of S. aureus NTCT8325 was performed using the Paver algorithm. As shown in the
Voronoi treemaps presented in Figure , the extracellular proteomes of the Q1–3 groups
have distinct functional signatures. In particular, 19 different functional
categories and 95 predicted protein functions were distinguished for
the Q1 group, the most prominently represented functional categories
being virulence, disease and defense (30.5%), protein metabolism (13.6%),
iron acquisition and metabolism (8.4%), and carbohydrate metabolism
(7.3%). For exoproteins of the Q2 group, 20 different functional categories
and 240 protein functions were assigned, with protein metabolism (19.5%),
virulence, disease, and defense (18.3%), carbohydrate metabolism (16.6%),
and iron acquisition and metabolism (4.5%) being the most prominent
categories. For exoproteins of the Q3 group, 21 functional categories
and 308 predicted protein functions were assigned, with protein metabolism
(21.1%), carbohydrates metabolism (14.9%), virulence, disease, and
defense (13.8%), and nucleosides and nucleotides (5.6%) being most
prominent. Altogether, the observations presented in Figures A,B and 4 imply that, over all, the core and variant exoproteomes of the investigated S. aureus t437 isolates have apparently distinctive
roles in pathogenesis and cellular functions.
Figure 4
Functional categories
and protein functions of identified extracellular
proteins within the Q1–3 groups. Voronoi treemaps created with
the Paver algorithm show the functional categories assigned to extracellular
proteins (left panels) and the respective protein names (right panels)
for each Q1–3 group. The different functional categories are
marked in different colors, and each protein is represented by a polygon-shaped
tile. The size of each category is proportional to the number of identified
proteins with the respective functions. In the panels on the right,
the relative abundance of each protein is indicated in color code.
Of note, particular proteins may have dual functions as exemplified
for IsdA and IsdB, which are involved both in iron acquisition and
virulence. Accordingly, these proteins are represented twice in the
panels on the right.
Functional categories
and protein functions of identified extracellular
proteins within the Q1–3 groups. Voronoi treemaps created with
the Paver algorithm show the functional categories assigned to extracellular
proteins (left panels) and the respective protein names (right panels)
for each Q1–3 group. The different functional categories are
marked in different colors, and each protein is represented by a polygon-shaped
tile. The size of each category is proportional to the number of identified
proteins with the respective functions. In the panels on the right,
the relative abundance of each protein is indicated in color code.
Of note, particular proteins may have dual functions as exemplified
for IsdA and IsdB, which are involved both in iron acquisition and
virulence. Accordingly, these proteins are represented twice in the
panels on the right.
Production of Known Virulence Factors by S. aureus t437 Isolates Is Highly Heterogeneous
Our exoproteome analyses
identified in total 35 proteins implicated in staphylococcal virulence.
The relative abundance of these known virulence factors as produced
by the individual investigated isolates is represented in Figure . Twelve of these
proteins are primarily linked with bacterial adhesion to cells and
tissues of the human host, including three iron-regulated surface
determinants (IsdA, IsdB, IsdH), six proteins belonging to the so-called
“microbial surface components recognizing adhesive matrix molecules”
(MSCRAMM) family (ClfA, ClfB, EbpS, Emp, FnbpA, FnbpB, Map, SpA, and
vWbp), and SasG. Eighteen identified virulence factors are secreted
proteins that serve to disrupt host cells and promote spreading, including
five exoenzymes (Aur, Lip1, Lip2, SC, and ScpA), five cytolytic toxins
(Hla, Hlb, Hld, LukD, and LukE), six superantigens (EntC2, EntK, EntQ,
SEIX, SSL7, and SSL11), and EsxA. In addition, we identified five
proteins (CHIPS, Efb, FLIPr, Sbi, and SCIN), which are involved in
the evasion of innate or adaptive immune responses of the host. As
shown in Figure ,
the expression of these 35 virulence factors by S. aureus t437 isolates was highly heterogeneous in the different groups of
isolates. In particular, isolates belonging to the Q1 group produced
on average less known virulence factors than isolates belonging to
the other two groups.
Figure 5
Heat map representation of the relative abundance of identified
extracellular virulence factors. A total number of 34 well-known virulence
factors was identified for the Q1–3 groups. Color-coded bars
within each heatmap represent identified proteins and their relative
abundance based on normalized total spectral counts. The isolate numbers
are indicated on top of each lane.
Heat map representation of the relative abundance of identified
extracellular virulence factors. A total number of 34 well-known virulence
factors was identified for the Q1–3 groups. Color-coded bars
within each heatmap represent identified proteins and their relative
abundance based on normalized total spectral counts. The isolate numbers
are indicated on top of each lane.
Subclustering of S. aureus t437 Isolates
Based on Normalized Total Spectral Counts of Exoproteins Is Predictive
for High or Low Rates of Killing in a Larval Infection Model
The observed differences in the production of known virulence factors
by the different S. aureus t437 isolates was
suggestive of possible differences in the virulence of these isolates.
Therefore, we assayed their virulence using a Galleria mellonella larval infection model, where the bacteria are solely challenged
by innate immune defenses.[18] Specifically,
each of the 20 investigated S. aureus t437 isolates
was used to infect 15 larvae, where a bacterial suspension of 10 μL
containing 2.5 × 106 CFUs in PBS was used per larval
inoculation. Subsequently, the larval mortality was assessed at 24
and 48 h post infection (p.i.). As a control, larvae were inoculated
with heat-killed bacteria equivalent to 2.5 × 107 CFU
prior to heat inactivation (i.e., a 10-fold higher CFU count than
used in inoculations with living bacteria). The vast majority of larvae
inoculated with heat-killed bacteria survived for 48 h p.i. (Figure ). In contrast, inoculation
with living bacteria resulted in death of the majority of larvae within
48 h p.i. Between different S. aureus t437 isolates,
the largest variations in larval killing were observed at 24 h p.i.,
while differences in the larval killing rates at 48 h p.i. were relatively
smaller. For example, inoculation with bacteria from the Q1 group
resulted in average killing rates between 17.7% (strain Q1–24)
and 57.7% (strain Q1–71) at 24 h p.i. At 48 h p.i. the larval
killing due to inoculation with isolates from the Q1 group ranged
between 51.1% (strain Q1–15) and 77.7% (strain Q1–71).
Similar larval killing rates were observed upon inoculation with S. aureus t437 isolates from groups Q2 and Q3. Of note,
the observed variations could not be correlated to geographical regions
where the S. aureus isolates had been collected,
different host environments, or particular MLVA types (Table ). However, for S. aureus isolates from the Q1, Q2, and Q3 groups, a clear correlation between
the larval killing rates and the k-means clustering-based
separation of isolates into different subclusters was observed. In
particular, isolates from the Q1a, Q2a, Q2c, Q3a, and Q3b subclusters
displayed relatively low-level killing of larvae (i.e., <40% killing
at 24 h p.i.), while isolates from the Q1b, Q1c, and Q2b subclusters
showed relatively high rates of larval killing (Figure ; Table S5). Only
among isolates from the Q3c subcluster we observed both high and low
rates of larval killing.
Figure 6
Virulence of the 20 investigated S. aureus t437 isolates in a G. mellonella infection
model. (A) Larvae of G. mellonella were inoculated
with 2.5 × 106 CFUs of the 20 S. aureus t437 study isolates. Killing of the larvae was assessed at 24 and
48 h post inoculation. All values are the mean ± the standard
deviation of three independent infection experiments. HK, heat-killed
bacteria. (B) Statistical significance of observed differences in
virulence between the identified S. aureus t437
subgroups as assessed using a Wilcoxon test. A P-value
<0.05 was considered significant.
Virulence of the 20 investigated S. aureus t437 isolates in a G. mellonella infection
model. (A) Larvae of G. mellonella were inoculated
with 2.5 × 106 CFUs of the 20 S. aureus t437 study isolates. Killing of the larvae was assessed at 24 and
48 h post inoculation. All values are the mean ± the standard
deviation of three independent infection experiments. HK, heat-killed
bacteria. (B) Statistical significance of observed differences in
virulence between the identified S. aureus t437
subgroups as assessed using a Wilcoxon test. A P-value
<0.05 was considered significant.To investigate which extracellular proteins might be involved
in
the differences in larval killing activity per “Q-group”,
we assessed the statistically significant differences in the abundance,
as well as the presence or absence, of particular exoproteins in the
respective subclusters with high or low killing activity. This revealed
that distinguishing features for Q1 isolates with high killing activity
(subclusters Q1b and Q1c) were the production of a secreted Chitinase
B (ChiB) and the amidase Sle1, relatively high levels of IsaA, and
relatively low levels of the IsdA and IsdB proteins (Table ). Interestingly, also for isolates
from the Q3 group with mostly high killing activity (Q3c), the identification
of Chitinase B was a distinguishing feature. Distinguishing features
of isolates with high killing activity in the Q2 group (i.e., subcluster
Q2b) were relatively high levels of IsdB, and the unique identification
of Efb, FnbB, IsdE, and SdrH (Table ). To verify possible effects of some of these extracellular
proteins on virulence, we tested isdA, isdB, or isaA mutant strains along with the respective
parental strains in the G. mellonella infection
model. Compared to the wild-type, the isdA and isdB mutations in the S. aureus USA300
LAC background displayed no significant differences in larval killing
(Figure A), whereas
the rate of larval killing by the investigated isaA mutant was significantly lower compared to the respective S. aureus SH1000 wild-type (Figure B). Taken together, these observations imply
that the k-means clustering analysis based on the
normalized total spectral counts of exoproteins that were produced
by all the isolates within each Q group distinguishes those isolates
that show comparable levels of virulence, at least in the G. mellonella infection model.
Table 2
Extracellular Proteins of S. aureus t437 Isolates Significantly or Uniquely Associated
with High or Low Virulence in the Galleria mellonella Infection Modela
Q1 a versus b and c
Iron-regulated surface determinant protein B (IsdB)
a↑
b and c↓
(P < 0.0001)
Iron-regulated surface determinant protein A
(IsdA)
a↑
b and c↓
(P = 0.0002)
Immunodominant staphylococcal
antigen A (IsaA)
a↓
b and c↑
(P < 0.0001)
Chitinase B (ChiB)
a–
b and c+
N-Acetylmuramyl-l-alanine amidase
(Sle1)
a–
b and c+
Q2 b versus a and c
Iron-regulated surface determinant protein B (IsdB)
Ser-Asp rich fibrinogen/bone
sialoprotein-binding protein (SdrH)
b+
a and c–
Fibronectin-binding protein B (FnbB)
b+
a and c–
Q3 c versus
a and b
Chitinase B (ChiB)
c+
a and b–
50S ribosomal protein (L7/L12)
c–
a and b+
50S ribosomal protein (L5)
c–
a and b+
Statistical significance in the
amounts of particular extracellular proteins per Q1–3 group
and the respective a,b,c subgroups was assessed by ANOVA; “↑”,
indicates a significantly higher level of protein abundance and “↓”
a significantly lower protein abundance level. Proteins consistently
present or absent in the respective groups and subgroups are indicated
with “+” or “–”, respectively.
Figure 7
Assessment of possible
roles of IsdA, IsdB, and IsaA in staphylococcal
virulence in a G. mellonella infection model.
(A) Effect of the inoculation of G. mellonella larvae (n = 30) with 1 × 106 CFUs
of S. aureus USA300 LAC, or isdA or isdB mutant derivatives of this strain on larval
survival. (B) Effect of the inoculation of G. mellonella larvae (n = 30) with 1 × 106 CFUs
of S. aureus SH1000 or an isaA mutant derivative of this strain on larval survival. The survival
rates were monitored from 24 to 96 h post infection. The statistical
significance of the observed differences was assessed using a Wilcoxon
test. A P-value < 0.05 was considered significant
(isdA vs wild-type, P = 0.8621; isdB vs LAC, P = 0.1642; isaA vs SH1000, P = 0.0325).
Assessment of possible
roles of IsdA, IsdB, and IsaA in staphylococcal
virulence in a G. mellonella infection model.
(A) Effect of the inoculation of G. mellonella larvae (n = 30) with 1 × 106 CFUs
of S. aureus USA300 LAC, or isdA or isdB mutant derivatives of this strain on larval
survival. (B) Effect of the inoculation of G. mellonella larvae (n = 30) with 1 × 106 CFUs
of S. aureus SH1000 or an isaA mutant derivative of this strain on larval survival. The survival
rates were monitored from 24 to 96 h post infection. The statistical
significance of the observed differences was assessed using a Wilcoxon
test. A P-value < 0.05 was considered significant
(isdA vs wild-type, P = 0.8621; isdB vs LAC, P = 0.1642; isaA vs SH1000, P = 0.0325).Statistical significance in the
amounts of particular extracellular proteins per Q1–3 group
and the respective a,b,c subgroups was assessed by ANOVA; “↑”,
indicates a significantly higher level of protein abundance and “↓”
a significantly lower protein abundance level. Proteins consistently
present or absent in the respective groups and subgroups are indicated
with “+” or “–”, respectively.
S. aureus t437 Isolates Show Relatively
Small Variations in Cytotoxicity in a HeLa Cell Infection Model
The observed differences in the larval killing activity by the
different S. aureus t437 isolates mostly reflect
the ability of the respective bacteria to survive a challenge by professional
phagocytes of G. mellonella. This prompted us
to also investigate their ability to invade and kill nonprofessional
phagocytic cells. To this end, we applied HeLa cells, which were exposed
to S. aureus at a MOI of 1:50. After 2 h, lysostaphin
was added to eliminate the extracellular, noninternalized bacteria
and an MTT activity assay was applied to evaluate the viability of
the infectedHeLa cells. The results are presented in Figure as the percentage of MTT activity
relative to that of the uninfected control cells. Interestingly, although
some variations in the killing of HeLa cells were observed, the differences
were mostly not significant (Figure B; Table S5). Of note, as
shown in Figure A,
a relatively low cytotoxicity was observed for three Panton-Valentine
Leukocidin (PVL)-deficient isolates (i.e., 57, 147, 153; Table ), and three isolates
that seem to lack the adhesin EbpS as judged by the present exoproteome
analysis (i.e., 15, 71, and 93; Figure ). Thus, the substantial differences observed for the
exoproteomes of the investigated S. aureus t437
isolates are not mirrored in the ability to invade and kill nonprofessional
phagocytic HeLa cells.
Figure 8
Cytotoxicity of the 20 investigated S. aureus t437 isolates in a HeLa cell infection model. (A) HeLa cells were
infected with bacteria at a MOI of 50:1. Upon 2 h incubation, lysostaphin
was added to eliminate the extracellular bacteria. After another 2
h incubation, MTT was added to evaluate the viability of the infected
HeLa cells. The results are shown as the percentage of MTT reduction
relative to the uninfected control. (B) The statistical significance
of differences in the killing of HeLa cells by S. aureus t437 PVL- or EbpS-negative isolates was assessed by t tests. Please note that the absence of PVL from particular strains
was previously demonstrated (Table ), and that the EbpS-negative designation relates to
a lack of identification of EbpS in the present exoproteome analysis. P-values < 0.05 were considered significant. The P-values for isolate 15 versus isolates 24, 54, and 59 are
0.0036, 0.0369, and 0.0149, respectively.
Cytotoxicity of the 20 investigated S. aureus t437 isolates in a HeLa cell infection model. (A) HeLa cells were
infected with bacteria at a MOI of 50:1. Upon 2 h incubation, lysostaphin
was added to eliminate the extracellular bacteria. After another 2
h incubation, MTT was added to evaluate the viability of the infectedHeLa cells. The results are shown as the percentage of MTT reduction
relative to the uninfected control. (B) The statistical significance
of differences in the killing of HeLa cells by S. aureus t437 PVL- or EbpS-negative isolates was assessed by t tests. Please note that the absence of PVL from particular strains
was previously demonstrated (Table ), and that the EbpS-negative designation relates to
a lack of identification of EbpS in the present exoproteome analysis. P-values < 0.05 were considered significant. The P-values for isolate 15 versus isolates 24, 54, and 59 are
0.0036, 0.0369, and 0.0149, respectively.
Discussion
In the present study, we have performed
a first comparative exoproteome
profiling analysis for S. aureus with the spa-type t437, including 20 isolates from eight different
countries. In a previous study, we described this clone as a genetically
tight cluster belonging to the CC59 clonal complex.[8] Nonetheless, our analysis uncovered substantial exoproteome
heterogeneity among these strains, and only relatively few proteins
were found to be produced by all investigated isolates. In contrast,
a large number of proteins was found to be unique for one or two strains
under the conditions tested. Of note, we have previously uncovered
substantial exoproteome heterogeneity for the S. aureus species by investigating clinical isolates derived from one hospital,
but belonging to different clonal lineages.[15] This was attributed to the large plasticity of the S. aureus genome, which is continuously reshaped by the acquisition and loss
of mobile genomic elements, as well as strain-specific differences
in gene expression, translation, protein secretion and post-translational
protein modifications.[40] On the other hand,
we demonstrated more recently that the exoproteomes of S. aureus USA300 isolates from the Copenhagen area in Denmark display fairly
homogeneous exoproteomes, of which the composition could be associated
with their epidemicity.[41] This appears
to be different for the closely related S. aureus t437 isolates in our present study, which were collected in different
European countries and China. Although it is suggestive that the geographical
distribution could play a role in the observed exoproteome heterogeneity,
it was not possible to associate particular exoproteome profiles to
particular countries or even to particular subtypes of S. aureus t437 as distinguished by MLVA or MultiLocus Variable-number tandem
repeat Fingerprinting. A similar observation was reported by Liew
et al., who compared pairs of S. aureus isolates
belonging to ST1, ST8 and ST33.[42] To date,
it was difficult to explain this exoproteome heterogeneity. Importantly,
however, our present data do shed light on possible underlying mechanisms,
in particular because a large extent of the observed variation relates
to the release or excretion of typical cytoplasmic proteins, whereas
the variations observed for proteins secreted with the aid of Sec-type
signal peptides were relatively small.In addition to proteins
which are actively exported from the cytoplasm
via different secretion systems, the Sec system in particular, the
exoproteomes of S. aureus and many other bacteria
contain large numbers of typical cytoplasmic proteins (Table S6).[43,44] Consequently, the numbers
of detectable extracellular proteins of S. aureus may become very large as exemplified by >1300 exoprotein identifications
in a recent study.[45] The mechanisms by
which these proteins are released from the cytoplasm have been enigmatic
for a long time. However, in recent years a general picture has emerged
where this so-called alternative secretion[46] or excretion of cytoplasmic proteins (ECP)[47] is the end result of different processes, involving cell lysis caused
by autolysins,[48] phage activity, the production
of cytolytic toxins,[49] and/or proteolytic
activity.[50] In the present study, we observed
a massive variation in the amounts of extracellular proteins to the
extent that we had to distinguish three groups (i.e., Q1, Q2, and
Q3) based on the total number of spectral counts of extracellular
proteins detected by MS. Interestingly, the variation in ECP could
not be correlated to the production of the major autolysin Atl, which
was detectable in comparable amounts in the exoproteomes of the different
isolates (Table S4). On the other hand,
we did observe a phage coat protein in the exoproteomes of isolates
belonging to groups Q2 and Q3 that displayed high levels of ECP. In
addition, among the exoproteomes of these isolates we detected the
phospholipase C, which is encoded by the hlb gene
into which the so-called β-hemolysin-converting bacteriophages
are usually integrated.[51] Such phages encode
immune evasion factors, like SCIN and CHIPS, which were abundantly
detected in the exoproteomes of the here investigated S. aureus t437 isolates. Hence, we consider it likely that the observed exoproteome
heterogeneity in groups Q2 and Q3 can be attributed at least to some
extent to (pro)phage activity. Intriguingly, we detected higher amounts
of the extracellular protease staphopain A in media of Q3 isolates,
and of the proteases aureolysin and SsaA1 in media of Q2 and Q3 isolates,
where the Q3 isolates show the highest levels of ECPs. This is different
from the situation encountered in B. subtilis where overproduction of secreted proteases led to complete degradation
of ECPs, whereas the deletion of multiple genes for secreted proteases
led to highly increased levels of ECPs.[39,52] The latter
was due both to decreased turnover of ECPs and enhanced autolysin
activity as secreted proteases are needed to control autolysin activity.
Likewise, a recent study using S. aureus USA300
LAC showed that increased protease production due to a sarA mutation resulted in a substantial reduction in the number of identified
extracellular proteins.[45] Thus, despite
the fact that extracellular proteases have been described as modulators
of virulence factor stability,[53] it seems
that other mechanisms like prophage activity are more dominant in
the appearance of ECPs in the investigated S. aureus t437 isolates.Irrespective of the precise mechanisms underlying
ECP, it has become
increasingly clear that certain cytoplasmic proteins can play decisive
roles in host colonization and infection. These multifunctional proteins
are usually described as “moonlighting proteins”. In
many cases, moonlighting proteins are evolutionarily well-conserved
metabolic enzymes or molecular chaperones.[54] For instance, glyceraldehyde-3-phosphate dehydrogenase (GAPDH),
the first identified moonlighting bacterial enzyme, was found to serve
not only as a glycolytic enzyme in the cytoplasm, but also as a virulence-enhancing
protein when associated with the cell surface of pathogenic streptococci.[55] In the exoproteomes of the S. aureus t437 lineage, we identified 3 well-known moonlighting proteins,
namely fructose-bisphosphate aldolase, alkyl hydroperoxide reductase
and elongation factor Tu. In fact, all investigated isolates showed
relatively high extracellular levels of these three proteins. The
cytoplasmic form of fructose-bisphosphate aldolase is a glycolytic
enzyme but, upon ECP by Candida albicans and Neisseria meningitides, this protein was shown to be involved
in plasminogen binding and adhesion to human cells.[56,57] The alkyl hydroperoxide reductase is generally responsible for detoxification
of reactive oxygen species, but it was also implicated in heme-binding
by Streptococcus agalactiae.[58] The cytoplasmic form of elongation factor Tu catalyzes the binding
of aminoacyl-tRNA to the ribosome but, when exposed on the surface
of Mycoplasma pneumoniae and Streptococcus
gordonii, it can also play roles in fibronectin- and mucin-binding,
respectively.[59,60] It thus seems that the release
of cytoplasmic proteins into the extracellular environment, either
by lysis or other mechanisms, can be regarded as an altruistic mechanism
for the bacterial population. On this basis, it can be anticipated
that several of the presently identified ECPs may serve additional
roles in host colonization and infections caused by S. aureus t437.One of the major challenges in understanding and predicting
the
virulence of S. aureus is imposed by the multitude
of virulence factors produced by this pathogen, all of them serving
different but sometimes overlapping, redundant or even synergistic
roles during different stages of infection. Accordingly, it has thus
far been close to impossible to correlate clinical data to particular
exoproteome profiles. We therefore made a first attempt to correlate
our exoproteome data to bacterial virulence in a simple high-throughput
animal model involving the larvae of Galleria mellonella. Of note, in this model bacteria are injected into the larvae, which
means that early stages in the infection process, like adhesion, colonization
and breakage of barriers for infection are bypassed. Instead, the
bacteria are directly confronted by the innate immune response of
the larvae.[18] Furthermore, for a number
of opportunistic human pathogens good correlations were observed between
infection of mice and G. mellonella.[61,62] Importantly, the Galleria model has already been
successfully applied in the identification of virulence factors of S. aureus, and the efficacy of anti-staphylococcal agents.[63,64] Intriguingly, we observed that particular
quantitative proteomic signatures within each Q-group of investigated S. aureus t437 isolates correlated well with high or
low virulence in the Galleria model, irrespective
of the numbers of different extracellular proteins produced. Instead,
certain proteins such as IsaA, IsdB, IsdA, IsdE, IsdH, and Chitinase
B could be related to the observed killing of larvae. For instance,
the housekeeping protein IsaA, which has been identified as a major
antigen of S. aureus and a potential candidate
for antibody-based therapy,[65] was a distinctive
feature of the exoproteome profile of the highly virulent subgroups
Q1b and Q1c. Consistent with this notion, an isaA deletion mutant was found to be attenuated in the G. mellonella infection model. A role of IsaA in staphylococcal virulence had
not yet been reported, but it would in fact explain why this protein
is invariantly produced in all investigated clinical S. aureus isolates.[15,66] Also, the hydrolytic enzyme Chitinase
B was uniquely present in the exoproteomes of the highly virulent
subgroups Q1b, Q1c, and Q3c. The impact of the latter enzyme could
in principle be due to the degradation of larval chitin.[67] However, it has to be noted that chitin and
chitinases were previously proposed to serve as important regulators
of innate and adaptive immune responses.[68] It is thus conceivable that the produced Chitinase B also serves
a function in immune evasion and infection, not only in the Galleria model, but even in the human body from which all
investigated S. aureus t437 isolates included
in our study were originally derived. Clearly, this will require further
in-depth analyses. Confidence that the observed exoproteome abundance
profiles may be meaningful for virulence of the investigated S. aureus isolates can be derived from the fact that
multiple proteins involved in iron homeostasis were found to be associated
with virulence, albeit in a differential manner. The latter may explain
why we did not observe a distinctive effect of individual isdA or isdB mutations on virulence in
the G. mellonella model. Nonetheless, the importance
of iron homeostasis determinants for virulence would be consistent
with the fact that both humans and G. mellonella represent an iron restricted environment for S. aureus, where iron deprivation may impose a need for high virulence whereas
a good ability to acquire iron may to some extent obviate the need
to be virulent. Thus, the fact that we can correlate certain S. aureus t437 exoproteome abundance profiles to high
or low virulence in the G. mellonella model
implies that these profiles may also be relevant for the potential
to cause infection in particular niches of the human body. In this
respect, one has to bear in mind that animal models, such as the larvae
of G. mellonella, reflect the human setting
only partially. Furthermore, different bacterial traits are required
to infect different niches in the human body. Consistent with this
view, the investigated S. aureus t437 isolates
behaved differently in the HeLa cell infection model, where we essentially
assayed their ability to invade and kill nonprofessional phagocytic
cells. In the latter infection scenario, it appears that the presence
or absence of the adhesin EbpS or the toxin PVL may have a greater
impact on the viability of infected host cells than the major differences
that we observed in the composition of the exoproteomes of the individual
investigated S. aureus t437 isolates.
Conclusion
The present study provides a detailed survey of the extracellular
proteome and virulence assessment of the S. aureus lineage with spa-type t437. The results allowed
a separation of 20 representative clinical isolates into three groups
and nine subclusters with different exoproteome abundance profiles.
This shows that, despite the high degree of genomic relatedness within
this lineage, its exoproteome is highly heterogeneous. This has important
bearings on the virulence of these isolates as was shown using a G. mellonella larval infection model. On the other
hand, the virulence of the investigated isolates as assayed in the
HeLa cell toxicity assay most likely mirrors the relatively few variations
observed for a core set of about 20 known extracellular virulence
factors that typify the S. aureus t437 lineage.
Here one has to bear in mind that S. aureus requires
different virulence factors to invade, thrive, and survive in different
niches of the human body. Thus, the present data provide novel leads
for further dissection of the roles of particular exoproteome profiles
or individual extracellular proteins in staphylococcal virulence.
Authors: Kwan Soo Ko; Ji-Young Lee; Ji Yoeun Suh; Won Sup Oh; Kyong Ran Peck; Nam Yong Lee; Jae-Hoon Song Journal: J Clin Microbiol Date: 2005-01 Impact factor: 5.948
Authors: Hilary F Clark; Austin L Gurney; Evangeline Abaya; Kevin Baker; Daryl Baldwin; Jennifer Brush; Jian Chen; Bernard Chow; Clarissa Chui; Craig Crowley; Bridget Currell; Bethanne Deuel; Patrick Dowd; Dan Eaton; Jessica Foster; Christopher Grimaldi; Qimin Gu; Philip E Hass; Sherry Heldens; Arthur Huang; Hok Seon Kim; Laura Klimowski; Yisheng Jin; Stephanie Johnson; James Lee; Lhney Lewis; Dongzhou Liao; Melanie Mark; Edward Robbie; Celina Sanchez; Jill Schoenfeld; Somasekar Seshagiri; Laura Simmons; Jennifer Singh; Victoria Smith; Jeremy Stinson; Alicia Vagts; Richard Vandlen; Colin Watanabe; David Wieand; Kathryn Woods; Ming-Hong Xie; Daniel Yansura; Sothy Yi; Guoying Yu; Jean Yuan; Min Zhang; Zemin Zhang; Audrey Goddard; William I Wood; Paul Godowski; Alane Gray Journal: Genome Res Date: 2003-09-15 Impact factor: 9.043
Authors: Jonathan D Crowe; Isla K Sievwright; Gillian C Auld; Norma R Moore; Neil A R Gow; Nuala A Booth Journal: Mol Microbiol Date: 2003-03 Impact factor: 3.501
Authors: Giorgio Gabarrini; Stefano Grasso; Arie Jan van Winkelhoff; Jan Maarten van Dijl Journal: Microbiol Mol Biol Rev Date: 2020-01-02 Impact factor: 11.056
Authors: Xin Zhao; Monika A Chlebowicz-Flissikowska; Min Wang; Elias Vera Murguia; Anne de Jong; Dörte Becher; Sandra Maaß; Girbe Buist; Jan Maarten van Dijl Journal: Virulence Date: 2020-12 Impact factor: 5.882
Authors: Yanyan Fu; Sandra Maaβ; Marines du Teil Espina; Anouk H G Wolters; Yanan Gong; Anne de Jong; Erwin Raangs; Girbe Buist; Johanna Westra; Dörte Becher; Jan Maarten van Dijl Journal: mSystems Date: 2022-06-13 Impact factor: 7.324